Skip to content
← Full study record

NCT04148651 · OUTCOME

Change From Baseline in Sexual Function on the Female Sexual Function Index (FSFI) at 3 Months and 6 Months After the Final Treatment

The CO2RE® System for Vulvar Lichen Sclerosus · Source last updated 2022-03-22

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
MEAN
Unit
units on a scale
Interval / dispersion
Standard Error
Time frame
Baseline and 3 months and 6 months after the final treatment

What was measured

Female Sexual Function Index (FSFI) is a validated, self-reported 19-item questionnaire that assesses domains of sexual function, including desire, arousal, lubrication, orgasm, satisfaction, and pain. The aggregated FSFI score is a sum of weighted answers for each of the 19 items in the questionnaire, with a maximum total score possible of 36.0 (high level of sexual functional) and minimum score of 2.0 (low level of sexual functional). Change = (Follow-up score - Baseline score). Mean change was calculated for all scores at the 3- and 6-month follow-ups.

Analysis population: At Baseline, 12 patients completed FSFI questionnaires. At the 3-month visit, 11 subjects completed the FSFI (one subject missed the visit). At the 6-month follow-up, 12 subjects completed the FSFI (one subject missed her visit but provided her self-assessments remotely).

Groups in this outcome

CO2RE® Treatment

All eligible subjects that underwent up to 5 treatments at 4±1-week intervals to the vulva with a fractional CO2 laser and maintained the protocol regimen. The CO2RE® System: The CO2RE® system is a fractional CO2 laser that is FDA-cleared under a 510(k) K181523 for laser incision, excision, ablation and/or vaporization and of soft tissue in gynecology (GYN).

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
CO2RE® Treatment12

Reported measurements

Mean Change in FSFI At the 3-Month Follow-up

Analysis denominator · Participants

GroupSource count
CO2RE® Treatment11
Values in units on a scale · Interval/dispersion: Standard Error
GroupValueSpreadLowerUpperComment
CO2RE® Treatment4.062.25Not reportedNot reportedNot reported
Mean Change in FSFI At the 6-Month Follow-up

Analysis denominator · Participants

GroupSource count
CO2RE® Treatment12
Values in units on a scale · Interval/dispersion: Standard Error
GroupValueSpreadLowerUpperComment
CO2RE® Treatment4.532.41Not reportedNot reportedNot reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        spread
        2.25
        value
        4.06
    denoms
    1. counts
      1. group Id
        OG000
        value
        11
      units
      Participants
    title
    Mean Change in FSFI At the 3-Month Follow-up
  2. categories
    1. measurements
      1. group Id
        OG000
        spread
        2.41
        value
        4.53
    denoms
    1. counts
      1. group Id
        OG000
        value
        12
      units
      Participants
    title
    Mean Change in FSFI At the 6-Month Follow-up
denoms
  1. counts
    1. group Id
      OG000
      value
      12
    units
    Participants
description
Female Sexual Function Index (FSFI) is a validated, self-reported 19-item questionnaire that assesses domains of sexual function, including desire, arousal, lubrication, orgasm, satisfaction, and pain. The aggregated FSFI score is a sum of weighted answers for each of the 19 items in the questionnaire, with a maximum total score possible of 36.0 (high level of sexual functional) and minimum score of 2.0 (low level of sexual functional). Change = (Follow-up score - Baseline score). Mean change was calculated for all scores at the 3- and 6-month follow-ups.
dispersion Type
Standard Error
groups
  1. description
    All eligible subjects that underwent up to 5 treatments at 4±1-week intervals to the vulva with a fractional CO2 laser and maintained the protocol regimen. The CO2RE® System: The CO2RE® system is a fractional CO2 laser that is FDA-cleared under a 510(k) K181523 for laser incision, excision, ablation and/or vaporization and of soft tissue in gynecology (GYN).
    id
    OG000
    title
    CO2RE® Treatment
param Type
MEAN
population Description
At Baseline, 12 patients completed FSFI questionnaires. At the 3-month visit, 11 subjects completed the FSFI (one subject missed the visit). At the 6-month follow-up, 12 subjects completed the FSFI (one subject missed her visit but provided her self-assessments remotely).
reporting Status
POSTED
time Frame
Baseline and 3 months and 6 months after the final treatment
title
Change From Baseline in Sexual Function on the Female Sexual Function Index (FSFI) at 3 Months and 6 Months After the Final Treatment
type
SECONDARY
unit Of Measure
units on a scale

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice